Utama › Fibrosis Paru Idiopatik › Texas
Kajian klinikal Fibrosis Paru Idiopatik di Texas
11 kajian untuk Fibrosis Paru Idiopatik sedang mencari peserta di lokasi di Texas.
Bandar di Texas
Teks kajian rasmi (Bahasa Inggeris)
An Extension Study of Subjects Who Received an Avalyn Inhaled Antifibrotic Agent (SAIL)
- El Paso Pulmonary Association, P.A., El Paso
- Baylor College of Medicine, Houston
Mengambil pesertaFasa 2
Umur 18 ke atas · Semua jantina · Dikemas kini 2 Okt 2026 · NCT06951217A Phase IIb Study to Evaluate AZD8965 in Participants With IPF.
- Research Site, Dallas
- Research Site, El Paso
- Research Site, Houston
Mengambil pesertaFasa 2
Umur 40 ke atas · Semua jantina · Dikemas kini 21 Sep 2026 · NCT07652658A Study to Find an Efficacious and Safe Dose of CHF10067 (Zampilimab) in Participants With Idiopathic Pulmonary Fibrosis
- Premier Pulmonary Critical Care and Sleep Medicine, PA, Denison
Mengambil pesertaFasa 2
Umur 40 ke atas · Semua jantina · Dikemas kini 17 Sep 2026 · NCT07516951RE104 Safety and Efficacy Study in Adjustment Disorder in Cancer and Other Medical Illnesses
- Dell Medical School, University of Texas at Austin, Austin
Mengambil pesertaFasa 2
Umur 18 hingga 80 · Semua jantina · Dikemas kini 15 Sep 2026 · NCT07002034Idiopathic Pulmonary Fibrosis (IPF)-Related Chronic Cough Reduction With Nalbuphine Extended-Release (NAL ER) Tablets
- Horizon Clinical Research Group, Cypress
- El Paso Pulmonary Association, PA, El Paso
- Elevate Clinical Research, Houston
Mengambil pesertaFasa 3
Umur 40 ke atas · Semua jantina · Dikemas kini 14 Sep 2026 · NCT07671911A Phase 2 Study of LTI-03 in Patients With Idiopathic Pulmonary Fibrosis
- El Paso Pulmonary Association, El Paso
- Baylor College of Medicine, Houston
- Baylor Scott and White Health, Temple
Mengambil pesertaFasa 2
Umur 40 ke atas · Semua jantina · Dikemas kini 4 Sep 2026 · NCT06968845Trial to Evaluate the Efficacy and Safety of LYT-100 (Deupirfenidone) Compared to Pirfenidone in Adults With Idiopathic Pulmonary Fibrosis (IPF)
- Premier Pulmonary Critical Care and Sleep Medicine, Denison
- Renovatio Clinical, The Woodlands
- Renovatio Clinical, Webster
Mengambil pesertaFasa 3
Umur 40 ke atas · Semua jantina · Dikemas kini 3 Sep 2026 · NCT07284602Oral Ifetroban in Patients With Idiopathic Pulmonary Fibrosis (IPF)
- Baylor University Medical Center, Dallas
- Premier Pulmonary Critical Care and Sleep Medicine, Denison
Mengambil pesertaFasa 2
Umur 40 ke atas · Semua jantina · Dikemas kini 2 Sep 2026 · NCT05571059Idiopathic Pulmonary Fibrosis and Interstitial Lung Disease Prospective Outcomes Registry
- University of Texas Southwestern, Dallas
- Baylor University Medical Center at Dallas, Dallas
- Baylor College of Medicine, Houston
- dan 2 lagi
Mengambil pesertaKajian pemerhatian
Umur 21 ke atas · Semua jantina · Dikemas kini 12 Ogo 2026 · NCT01915511WISPer: Evaluation of MTX-463 in Participants With Idiopathic Pulmonary Fibrosis (IPF)
- WISPer site in Dallas, TX, Dallas
Mengambil pesertaFasa 2
Umur 40 ke atas · Semua jantina · Dikemas kini 10 Ogo 2026 · NCT06967805Study Evaluating INS018_055 Administered Orally to Subjects With Idiopathic Pulmonary Fibrosis
- University of Texas Southwestern Medical Center, Dallas
- Metroplex Pulmonary and Sleep Center, McKinney
- Research Centers of America, McKinney
Mengambil pesertaFasa 2
Umur 40 ke atas · Semua jantina · Dikemas kini 12 Nov 2025 · NCT05975983Daripada ClinicalTrials.gov, data diperoleh pada 5 Okt 2026. Setiap kajian menetapkan kriteria kelayakannya sendiri; pasukan kajian menentukan siapa yang layak menyertai.